Industry Developments
Canada
Following disappointing financial results, Canadian firm Biovail has revealed a restructuring plan. The drugmaker will close two foreign manufacturing plants and will increasingly...
2008-05-12Thailand
BMI estimates that over 95% of global pharmaceutical sales are made by private enterprises, and predicts that this figure will increase in the future. State-run drugmakers are an...
2008-04-29Mexico
In what could be a significant boost to the self-sufficiency of Mexico's pharmaceutical market, state-owned vaccine maker Laboratorios de Biológicos y Reactivos de México (Birmex)...
2008-04-09United States
The usual bold plans for using trade to leverage improved intellectual property (IP) provisions were contained within the Office of the US Trade Representative (USTR)'s 2008 National...
2008-04-08Brazil
Two of Latin America's leading drugmakers are to collaborate to initiate an intra-region tie-up. Mexico's Laboratories Silanes and Brazil's Aché Laboratórios Farmacêuticos have...
2008-04-04Brazil
A survey by researchers at Brazil's Londrina State University has suggested that a lack of information on the correct use of medicines is resulting in a heightened risk of misuse...
2008-04-03Jamaica
BMI recently voiced its concerns as to the affordability of the Jamaica Labour Party's manifesto promise of 'free public hospital care'. The pledge became reality on April 1. The...
2008-04-01Jamaica
BMI recently voiced its concerns as to the affordability of the Jamaica Labour Party's manifesto promise of 'free public hospital care'. The pledge became reality on April 1. The...
2008-04-01Dominican Republic
France's Sanofi-Aventis is gearing up for a battle over the validity of its patent for anti-clotting agent Plavix (clopidogrel) in the Dominican Republic, according to the Dominican...
2008-03-31Dominican Republic
France's Sanofi-Aventis is gearing up for a battle over the validity of its patent for anti-clotting agent Plavix (clopidogrel) in the Dominican Republic, according to the Dominican...
2008-03-31




